Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
156.84
-0.08 (-0.05%)
At close: Mar 23, 2026, 4:00 PM EDT
157.49
+0.65 (0.41%)
After-hours: Mar 23, 2026, 5:07 PM EDT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of $8.02 billion as of March 23, 2026. Its market cap has increased by 34.66% in one year.
Market Cap
8.02B
Enterprise Value
7.92B
1-Year Change
34.66%
Ranking
Category
Stock Price
$156.84
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from $154.90M to $8.02B, an increase of 5,079.39%. That is a compound annual growth rate of 46.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 8.02B | -12.86% |
| Dec 31, 2025 | 9.21B | 124.55% |
| Dec 31, 2024 | 4.10B | 8.87% |
| Dec 29, 2023 | 3.77B | 12.44% |
| Dec 30, 2022 | 3.35B | 135.22% |
| Dec 31, 2021 | 1.42B | -53.19% |
| Dec 31, 2020 | 3.04B | -14.70% |
| Dec 31, 2019 | 3.57B | 4,141.14% |
| Dec 31, 2018 | 84.10M | -36.58% |
| Dec 29, 2017 | 132.60M | 2.55% |
| Dec 30, 2016 | 129.30M | -21.30% |
| Dec 31, 2015 | 164.30M | 6.07% |
| Nov 19, 2015 | 154.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 9.37B |
| ImmunityBio | 8.71B |
| Praxis Precision Medicines | 8.31B |
| Bio-Techne | 8.05B |
| Arrowhead Pharmaceuticals | 7.89B |
| Vaxcyte | 7.88B |
| Cytokinetics | 7.60B |
| Halozyme Therapeutics | 7.49B |